These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 11774104

  • 1. Fluvastatin improves lipid abnormalities in patients with moderate to advanced chronic renal insufficiency.
    Samuelsson O, Attman PO, Knight-Gibson C, Mulec H, Weiss L, Alaupovic P.
    Am J Kidney Dis; 2002 Jan; 39(1):67-75. PubMed ID: 11774104
    [Abstract] [Full Text] [Related]

  • 2. Effect of fluvastatin on plasma apolipoprotein-B-containing particles, including lipoprotein(a). European Fluvastatin Study Group.
    Dallongeville J, Fruchart JC, Pfister P, Bard JM.
    J Intern Med Suppl; 1994 Jan; 736():95-101. PubMed ID: 7986315
    [Abstract] [Full Text] [Related]

  • 3. Effects of fluvastatin, a new inhibitor of HMG-CoA reductase, and niceritrol on serum lipids, lipoproteins and cholesterol ester transfer activity in primary hypercholesterolemic patients.
    Sasaki J, Yamamoto K, Kobori S, Setoguchi Y, Sato Y, Matsunaga A, Shichiri M, Sakai T, Kono S, Arakawa K.
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):420-6. PubMed ID: 7582401
    [Abstract] [Full Text] [Related]

  • 4. Effect of fluvastatin on apolipoprotein-defined lipoprotein subclasses in patients with chronic renal insufficiency.
    Alaupovic P, Attman PO, Knight-Gibson C, Mulec H, Weiss L, Samuelsson O.
    Kidney Int; 2006 May; 69(10):1865-71. PubMed ID: 16572113
    [Abstract] [Full Text] [Related]

  • 5. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA, Cachofeiro V, Masana L, Suarez C, Pinilla B, Plana N, Trias F, Moreno MA, Gambus G, Lahera V, Pintó X.
    Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
    [Abstract] [Full Text] [Related]

  • 6. Elderly patients with hypercholesterolaemia: a double-blind study of the efficacy, safety and tolerability of fluvastatin.
    Lye M, Valacio R, Reckless JP, Ghosh AK, Findlay IN, Ghosh MK, Passmore AP, Fulcher RA.
    Coron Artery Dis; 1998 Jan; 9(9):583-90. PubMed ID: 9861520
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of once-daily vs twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia.
    Insull W, Black D, Dujovne C, Hosking JD, Hunninghake D, Keilson L, Knopp R, McKenney J, Stein E, Troendle AJ.
    Arch Intern Med; 1994 Nov 14; 154(21):2449-55. PubMed ID: 7979841
    [Abstract] [Full Text] [Related]

  • 9. Fluvastatin for dyslipoproteinemia, with or without concomitant chronic renal insufficiency.
    Lintott CJ, Scott RS, Bremer JM, Shand BI.
    Am J Cardiol; 1995 Jul 13; 76(2):97A-101A. PubMed ID: 7604809
    [Abstract] [Full Text] [Related]

  • 10. The effect of fluvastatin on cardiac outcomes in patients with moderate to severe renal insufficiency: a pooled analysis of double-blind, randomized trials.
    Holdaas H, Wanner C, Abletshauser C, Gimpelewicz C, Isaacsohn J.
    Int J Cardiol; 2007 Apr 12; 117(1):64-74. PubMed ID: 16889855
    [Abstract] [Full Text] [Related]

  • 11. Treatment of primary hypercholesterolemia: fluvastatin versus bezafibrate.
    Greten H, Beil FU, Schneider J, Weisweiler P, Armstrong VW, Keller C, Klör HU, von Hodenberg E, Weidinger G, Eskötter H.
    Am J Med; 1994 Jun 06; 96(6A):55S-63S. PubMed ID: 8017468
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of fluvastatin alone or in combination with ezetimibe on lipoprotein subfractions in patients at high risk of coronary events.
    Stojakovic T, de Campo A, Scharnagl H, Sourij H, Schmölzer I, Wascher TC, März W.
    Eur J Clin Invest; 2010 Mar 06; 40(3):187-94. PubMed ID: 20067513
    [Abstract] [Full Text] [Related]

  • 13. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G, Cicero AE, Bertone G, Piccinni MN, Ciccarelli L, Roggeri DE.
    Clin Ther; 2004 Oct 06; 26(10):1599-607. PubMed ID: 15598476
    [Abstract] [Full Text] [Related]

  • 14. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.
    Christidis DS, Liberopoulos EN, Kakafika AI, Miltiadous GA, Liamis GL, Kakaidi B, Tselepis AD, Cariolou MA, Elisaf MS.
    Arch Med Res; 2007 May 06; 38(4):403-10. PubMed ID: 17416287
    [Abstract] [Full Text] [Related]

  • 15. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA.
    Br J Clin Pract Suppl; 1994 Dec 06; (77):28-32. PubMed ID: 19496270
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of fluvastatin in patients with non-insulin-dependent diabetes mellitus and hyperlipidemia.
    Knopp RH, Frohlich J, Jokubaitis LA, Dawson K, Broyles FE, Gomez-Coronado D.
    Am J Med; 1994 Jun 06; 96(6A):69S-78S. PubMed ID: 8017470
    [Abstract] [Full Text] [Related]

  • 18. Impact of fluvastatin on hyperlipidemia after renal transplantation.
    Tokumoto T, Tanabe K, Ishida H, Shimmura H, Ishikawa N, Goya N, Akiba T, Toma H.
    Transplant Proc; 2004 Sep 06; 36(7):2141-4. PubMed ID: 15518777
    [Abstract] [Full Text] [Related]

  • 19. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.
    Broyles FE, Walden CE, Hunninghake DB, Hill-Williams D, Knopp RH.
    Am J Cardiol; 1995 Jul 13; 76(2):129A-135A. PubMed ID: 7604788
    [Abstract] [Full Text] [Related]

  • 20. Effect of fluvastatin on lipoprotein profiles in treating renal transplant recipients with dyslipoproteinemia.
    Li PK, Mak TW, Chan TH, Wang A, Lam CW, Lai KN.
    Transplantation; 1995 Oct 15; 60(7):652-6. PubMed ID: 7570971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.